logo
Why Travelers Are Heading To London For Superclinic Skincare

Why Travelers Are Heading To London For Superclinic Skincare

Forbesa day ago
Welcome to a new era of wellness, a term that is no longer defined by simple treatments, such as massages and facials, but rather a holistic concept that, these days, means a 360° approach to how we look and feel. What's more, the appetite for 'deep dives' into the culture of wellness has become a top reason as to why people travel in 2025, with wellness tourism reported as one of the fastest growing sectors in the industry.
The 2024 Wellness Tourism Initiative report, by the Global Wellness Institute, pinpoints a 'diagnostic boom in wellness travel' as a major trend for this year. This surge, says the report, reflects 'a growing preference for tailored and proactive health approaches among travellers. Many health and wellness operators now offer comprehensive diagnostic assessments alongside traditional wellness activities, enhancing the overall visitor experience.'
Inside the HVN in Knightsbridge, one of London's 'super clinics'. (Credit: AVC)
The report continues: 'These offerings empower individuals to gain profound insights into their health status and make informed lifestyle choices while indulging in the rejuvenating benefits of travel. As travellers increasingly prioritize preventive healthcare and holistic well-being, the diagnostic booms in wellness travel are set to continue to reshape the tourism industry by seamlessly blending medical expertise with luxury hospitality.'
When it comes to the wellness scene in London, this couldn't be truer. The city has witnessed a growth in state-of-the-art clinics and wellness hubs, of late, that are offering personalised, cutting-edge treatments all with diagnosis at their heart. The luxury club Surrenne, at the five-star hotel The Emory, for instance, is focusing on longevity with functional diagnostics ranging from cardiovascular and hormone tests to microbiome mapping. While the The HVN in Knightsbridge puts personalisation as its priority and offers everything from acupuncture to aesthetic treatments.
In fact, the field of aesthetics has grown to become one of London's big draws for wellness travelers, with a host of expert names, working out of Harley Street and from their own clinics across the capital. Perhaps, unexpectedly, luxury hotels are also catching on to the trend with big name properties offering the latest in skincare by partnering with well-respected aesthetic doctors to offer guests scientific-led treatments.
The Langham is one of London's top hotels which has collaborated with a leading aesthetic doctor, Dr Soni. (credit: AVC)
The Corinthia hotel in Whitehall, for instance has collaborated with The London Regenerative Institute, which has opened up at its ESPAlife spa. Founded by renowned plastic surgeons Mr Tunc Tiryaki and Dr Steve Cohen, the clinic offers restorative aesthetic treatments that enhance longevity.
While at The Lanesborough Club and Spa, guests can book in for 'advanced aesthetic' treatments, such as Soft Wave or Exosome facials, with Dr Galyna, an award-winning aesthetic doctor and wellness expert.
Dr Soni's clinic at The Langham hotel offers the latest in aesthetic and holistic treatments. (Credit: Rebecca Searle)
Dr Aswin Soni, a UK and US trained plastic and reconstructive surgeon (and the founder and owner of The Soni Clinic in Ascot) is the expert at hand at The Langham's Chuan Spa. Known for championing 'gentle rejuvenation' when it comes to anti-ageing treatments, his client-list is full to bursting with A-listers, who arrive for his 'light touch', undetected at the luxury hotel via a private entrance to his consulting room.
Having studied at Imperial College, London, and trained in plastic surgery at Cornell in NYC, John Hopkins Hospital in Baltimore and Royal Marsden Hospital in London, Dr Soni brings a medical approach and advanced know-how to his procedures, which vary from polynucleotides injectables to dermal fillers, with a focus on natural-looking and subtle results.
With a background in plastic surgery, Dr Soni brings a science-led approach to skincare. (Credit: Rebecca Searle)
'It's not about changing how anyone looks,' he says. 'It's all about enhancing. A big part of my job is the consultation. I never give an opinion on what I think needs to be changed, because it is not about me. I listen and ask questions and then we come up with a plan that is bespoke for each of my clients.'
Being based in a central London hotel, many of Dr Soni's clients are, in fact, frequent travelers (as well as high profile names), and he has adapted his approach to treat the effects that long-haul travel can have on their skin.
'Patients who travel a lot have more dehydrated skin in general, as there is lower humidity on planes which leads to skin dryness,' he says. 'Dehydrated skin leads to more fine lines and wrinkles, issues with pores, and changes to the texture and quality of skin.'
The Alumier Aqua Infusion Mask is a must-have for travelers, according to Dr Soni. (credit: Alumier)
He continues: 'I always tell my clients to use a hydrating moisturiser when they are flying and, if they can, to take a hydrating sheet mask to use on board. AlumierMD Aqua Infusion Mask is my secret must-have when I am flying. You simply apply it like a moisturiser, but it infuses the skin with deep hydration.'
London's current spike in wellness offerings has been described in a recent issue of Harpers Bazaar as 'the rise of the superclinic' with the 'new generation of luxurious cosmetic centres here to cater for a discerning consumer for whom tweakments are as normal as a dental check-up.'
Travel and wellness go hand in hand, says Dr Soni. (Credit: Rebecca Searle)
Dr Soni agrees that the landscape in the capital city has changed. 'It certainly feels like an exciting time to be working here,' he says. 'What's more, the narrative within the aesthetic industry has aso evolved over the past few years. Patients no longer want a 'quick fix' but are focusing on long term skin health and quality. It feels more holistic, rather than surface level. As providers, we are not just thinking about what patients will look like in the next few months but, instead, it's more about the next few years.'
'A big development of late has been regenerative injectables, with collagen biostimulators, such as Sculptra by Galderma, and Plinest HPT polynucleotides by Dermafocus, at the forefront of this movement. The worlds of aesthetics and wellness have truly merged.'
Sulptra gives a healthy-looking, youthful result. (Credit: Sculptra)
An 'alternative' to filler, Sculptra is a regenerative injectable that helps stimulate your own natural collagen production to smooth facial wrinkles and improve skin tightness, revealing a 'refreshed-looking' you. Dr Soni explains: 'After the age of 20, we lose about 1% of collagen per year. Sculptra is the first and original poly-L-lactic acid (PLLA-SCA) facial injectable that targets fine lines, wrinkles, sagging, and other signs of ageing due to collagen loss, gradually helping restore skin structure and volume.'
Also in demand, says Dr Soni, is Dermafocus—a combination injectable which combines HPT polynucleotides with a skin booster. 'You get the regenerative effects from the polynucleotides, which includes collagen and elastin stimulation, as well as the hydration from the hyaluronic acid, so it is an all-round winner.'
The Soni Clinic is a hub for those looking for subtle and natural skincare treatments. (Credit: AVC)
'At times, the aesthetics industry has had a bad rep,' says Dr Soni. 'That is mostly down to bad practitioners and horror stories when things go wrong. But, just like with any true luxury experience—including travel—it is all about a personalised, finessed approach, you can say the same for skincare. My advice is to choose your practitioner wisely.'
'At the moment, there is so much innovation going on within the world of skincare and London is at the heart of that. Many science-backed brands are really innovating and researching at an incredible rate. As the trends change towards collagen stimulation, and the health and quality of skin, certain brands are staying ahead, and innovating with thoughtful and innovative peptides, unique antioxidant formulations, and pioneering approaches to sunscreen. It is an industry on the rise and one that is at the forefront of science—the rockbed of the wellness industry, if you like. After all, if you look good, you will feel good.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Adia Nutrition Inc. Celebrates Approval as Aetna Health Insurance Provider and Anticipates United Healthcare Approval for Adia Med Subsidiary
Adia Nutrition Inc. Celebrates Approval as Aetna Health Insurance Provider and Anticipates United Healthcare Approval for Adia Med Subsidiary

Yahoo

time28 minutes ago

  • Yahoo

Adia Nutrition Inc. Celebrates Approval as Aetna Health Insurance Provider and Anticipates United Healthcare Approval for Adia Med Subsidiary

Winter Park, Florida--(Newsfile Corp. - July 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized wellness solutions, is thrilled to announce that its medical subsidiary, Adia Med, has been approved as an in-network provider for Aetna health insurance, effective Friday, July 25, 2025. Additionally, Adia Med remains on track for approval as a provider with United Healthcare by this Friday, August 1, 2025, marking significant milestones in expanding access to its cutting-edge regenerative therapies and nutritional services. Aetna HealthTo view an enhanced version of this graphic, please visit: This approval with Aetna allows Adia Med to serve approximately 39 million members across the United States, tapping into Aetna's extensive network of 1.8 million health professionals, including 828,000 primary care providers and specialists, and over 6,200 hospitals. Aetna's health plans, with Affordable Care Act (ACA) marketplace plans averaging $647 monthly, provide robust coverage for services like Medical Nutrition Therapy (MNT) and regenerative treatments, aligning with Adia Med's offerings in chronic disease management and advanced therapies such as Autologous Hematopoietic Stem Cell Transplantation (AHSCT) and Therapeutic Plasma Exchange (TPE). Adia Med is also in the final stages of approval with United Healthcare, the nation's largest health insurer with a 15% market share, serving millions of members. This anticipated approval by August 1, 2025, will further broaden access to Adia Med's innovative treatments, including stem cell therapies and nutritional counseling, for a vast patient population. The company has already begun submitting its first patient insurance claims through United Healthcare, signaling imminent integration into their network. Financial Impact of Insurance Partnerships Aetna processes claims for its 39 million members, with annual medical expenditures estimated in the tens of billions of dollars, covering hospitalization, surgical, medical, vision, and prescription drug expenses. United Healthcare similarly manages billions in annual medical payouts, supporting a wide range of services from primary care to specialized treatments. These partnerships position Adia Nutrition and its Adia Med subsidiary to access significant reimbursement pathways, enhancing affordability and reach for its regenerative medicine and nutritional services. "We are overjoyed to join Aetna's provider network and are eagerly awaiting our approval with United Healthcare," said Larry Powalisz, CEO of Adia Nutrition Inc. "These partnerships validate the clinical excellence of Adia Med's regenerative therapies and nutritional programs, enabling us to deliver transformative care to millions while driving scalable growth in the $15.1 billion global stem cell market." For questions, inquiries or further information, please contact Larry Powalisz at ceo@ or 321-788-0850. About ADIA Nutrition Inc.:Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical (X): @ADIA_NutritionSafe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

England's Euro-winning squad return home for more celebrations
England's Euro-winning squad return home for more celebrations

Yahoo

timean hour ago

  • Yahoo

England's Euro-winning squad return home for more celebrations

England's victorious European championship squad is due to return to Britain on Monday to continue celebrations at the London residence of the British prime minister and along the streets of central London. Soon after their flight from Switzerland touches down on Monday afternoon, the players and coaches will be taken to a reception at 10 Downing Street hosted by Angela Rayner, the Deputy Prime Minister, and Stephanie Peacock, the Sports Minister. On Tuesday afternoon, they will travel along The Mall in central London in an open-top bus and soak up the plaudits from fans at the Queen Victoria Memorial in front of Buckingham Palace. "I'm very much looking forward to it all," said England head coach Sarina Wiegman on Sunday night after her side had overcome world champions Spain 3-1 in a penalty shoot-out. During the final at the St Jakob Park in Basel, Spain took the lead midway through the first-half through Mariona Caldentey. Just before the hour mark, Alessia Russo levelled for England. Though Spain dominated possession, they were unable to penetrate England's rear guard. Neither side was able to find the winner in 30 minutes of extra- time. During the shoot-out, England goalkeeper Hannah Hampton saved two kicks and after Salma Paralluelo missed Spain's fourth shot, Chloe Kelly stepped up and thrashed the ball high to the right of the Spain goalkeeper Cata Coll to launch the partying. "I'm so incredibly proud of the team and the staff," said Wiegman following England's third comeback win of the knockout stages. "This is the most chaotic and ridiculous tournament we have played," added the 55-year-old Dutchwoman. "In the quarter-final, semi-final and final we've come from behind. Of course, we have players with talent but the belief is incredible. They believe they can win by any means. We just never ever give up." Return Just over three weeks after losing their opening game of the tournament against France, Sunday night's triumph allowed England to become the first nation to secure back-to-back titles since Germany claimed six on the trot between 1995 and 2013. The success also enabled Wiegman to emulate the Germans Tina Theune and Gero Bisanz as the only coaches to have steered a squad to glory on three occasions. In 2017, Wiegman led the Netherlands to the crown with a 4-2 win over Denmark. In 2022, in a competition delayed to the coronavirus pandemic, she guided England to their first title at the expense of Germany. And three years later, she navigated her outfit past a Spain side that had won all of its games and featured the two-time Ballon D'Or winners Aitana Bonmati and Alexia Putellas. Bonmati, whose spot kick was saved in the shoot-out, said: "I think that in terms of football we have been the team that has played the best football in the tournament. "We are the players or the team that has the most talent, the one that is the most enjoyable to watch. But sometimes that's not enough." Spain head coach Montse Tomé echoed her star midfielder. "But hey, football is a sport where sometimes the best team doesn't always win," she added. "England is a great team and played well throughout the tournament, demonstrating a high level of competitiveness. "In the end, a penalty kick is something anyone can score, and anyone can miss."

Older Breast Cancer Patients Face Inconsistent Bone Care
Older Breast Cancer Patients Face Inconsistent Bone Care

Medscape

timean hour ago

  • Medscape

Older Breast Cancer Patients Face Inconsistent Bone Care

TOPLINE: Bone health management for older women with breast cancer receiving aromatase inhibitors (AIs) varied substantially across five UK hospitals. Despite the higher risk for fractures, women older than 80 years were less likely to receive DEXA scans or bisphosphonates, highlighting the urgent need for standardised bone monitoring and treatment in frail older patients. METHODOLOGY: This secondary analysis of the multicentre Age Gap study included 529 women (age, ≥ 70 years) with oestrogen receptor-positive early breast cancer who received AIs, either as primary or adjuvant treatment, at five hospitals in the UK. Researchers collected comprehensive data including the type of endocrine therapy, DEXA scan results, bisphosphonate usage, calcium and vitamin D supplementation, and the incidence of fractures during or after AI therapy. Frailty was assessed using a modified Rockwood Frailty Index, with scores being calculated across 75 variables to categorise patients as robust (< 0.08), prefrail (0.08-0.25), or frail (> 0.25). TAKEAWAY: Overall, 67% of patients had baseline DEXA scans. Of these, 42% were osteopenic and 18% osteoporotic. Scans were more common in 70- to 79-year-olds than in those aged 80 years or older and in women undergoing surgery than in those undergoing primary endocrine therapy, with marked variation across centres (P < .001 for all). Among patients receiving AI therapy, 43% were prescribed bisphosphonates, especially those who had surgery (hazard ratio [HR], 1.36; P = .04) and those aged 70-79 years (HR, 1.31; P = .02); 33% had vitamin D plus calcium along with bisphosphonates. During follow-up, 23% of patients had fractures, with significant variation across centres (P = .02), and 38% of these patients had received prior bisphosphonates. Although 94% of patients were frail or prefrail, frailty did not correlate with baseline hip (P = .10) or spine (P = .89) T scores. Bisphosphonates plus AIs were prescribed in 70% of non-frail participants vs 43% of prefrail and 47% of frail participants (P = .02). IN PRACTICE: "Patient's age and general health influence bone health decision making, with older and frailer patients often receiving non-standard care. Despite national and international recommendations, there is still wide variation in bone health management, highlighting the need for further education and standardised bone health care in older women with breast cancer," the authors wrote. SOURCE: This study was led by Elisavet Theodoulou, University of Sheffield, Sheffield, England. It was published online on July 18, 2025, in the Journal of Geriatric Oncology. LIMITATIONS: The study's inclusion of only five hospital sites limited the ability to draw broader conclusions about bone health management practices across a wider range of centres. Additionally, the interpretation of the results was complicated by the introduction of adjuvant bisphosphonates during the study period, making the cohort unstable in terms of bisphosphonate usage indications. DISCLOSURES: The Age Gap study was supported by the National Institute for Health and Care Research Programme Grants for Applied Research. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store